198 related articles for article (PubMed ID: 37426420)
1. Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction.
Clarke JP; Thibault PA; Fatima S; Salapa HE; Kalyaanamoorthy S; Ganesan A; Levin MC
Front Mol Biosci; 2023; 10():1178439. PubMed ID: 37426420
[TBL] [Abstract][Full Text] [Related]
2. Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation.
Clarke JWE; Thibault PA; Salapa HE; Kim DE; Hutchinson C; Levin MC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809384
[TBL] [Abstract][Full Text] [Related]
3. Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells.
Anees A; Salapa HE; Thibault PA; Hutchinson C; Hammond SA; Levin MC
eNeuro; 2021; 8(6):. PubMed ID: 34697074
[TBL] [Abstract][Full Text] [Related]
4. Methylarginines within the RGG-Motif Region of hnRNP A1 Affect Its IRES Trans-Acting Factor Activity and Are Required for hnRNP A1 Stress Granule Localization and Formation.
Wall ML; Lewis SM
J Mol Biol; 2017 Jan; 429(2):295-307. PubMed ID: 27979648
[TBL] [Abstract][Full Text] [Related]
5. Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells.
Ko CC; Chen YJ; Chen CT; Liu YC; Cheng FC; Hsu KC; Chow LP
J Biol Chem; 2014 Aug; 289(32):22078-89. PubMed ID: 24962584
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis.
Douglas JN; Gardner LA; Salapa HE; Levin MC
J Clin Cell Immunol; 2016 Apr; 7(2):402. PubMed ID: 27375925
[TBL] [Abstract][Full Text] [Related]
7. Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation.
Hamilton BJ; Burns CM; Nichols RC; Rigby WF
J Biol Chem; 1997 Nov; 272(45):28732-41. PubMed ID: 9353343
[TBL] [Abstract][Full Text] [Related]
8. Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.
Zhang L; Chen Q; An W; Yang F; Maguire EM; Chen D; Zhang C; Wen G; Yang M; Dai B; Luong LA; Zhu J; Xu Q; Xiao Q
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2182-2194. PubMed ID: 28912364
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC
J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424
[TBL] [Abstract][Full Text] [Related]
10. Phase Separation of Heterogeneous Nuclear Ribonucleoprotein A1 upon Specific RNA-Binding Observed by Magnetic Resonance.
Ritsch I; Lehmann E; Emmanouilidis L; Yulikov M; Allain F; Jeschke G
Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202204311. PubMed ID: 35866309
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional RNA binding proteins and stress granules in multiple sclerosis.
Salapa HE; Johnson C; Hutchinson C; Popescu BF; Levin MC
J Neuroimmunol; 2018 Nov; 324():149-156. PubMed ID: 30190085
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis models.
Libner CD; Salapa HE; Hutchinson C; Stang TE; Thibault PA; Hammond SA; Levin MC
Neurobiol Dis; 2022 Aug; 170():105775. PubMed ID: 35618205
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs.
Cammas A; Pileur F; Bonnal S; Lewis SM; Lévêque N; Holcik M; Vagner S
Mol Biol Cell; 2007 Dec; 18(12):5048-59. PubMed ID: 17898077
[TBL] [Abstract][Full Text] [Related]
14. Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation.
Lewis SM; Veyrier A; Hosszu Ungureanu N; Bonnal S; Vagner S; Holcik M
Mol Biol Cell; 2007 Apr; 18(4):1302-11. PubMed ID: 17287399
[TBL] [Abstract][Full Text] [Related]
15. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.
Jean-Philippe J; Paz S; Lu ML; Caputi M
Biochim Biophys Acta; 2014; 1839(4):251-8. PubMed ID: 24530421
[TBL] [Abstract][Full Text] [Related]
16. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins.
Duan Y; Du A; Gu J; Duan G; Wang C; Gui X; Ma Z; Qian B; Deng X; Zhang K; Sun L; Tian K; Zhang Y; Jiang H; Liu C; Fang Y
Cell Res; 2019 Mar; 29(3):233-247. PubMed ID: 30728452
[TBL] [Abstract][Full Text] [Related]
17. Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.
Black AC; Luo J; Watanabe C; Chun S; Bakker A; Fraser JK; Morgan JP; Rosenblatt JD
J Virol; 1995 Nov; 69(11):6852-8. PubMed ID: 7474099
[TBL] [Abstract][Full Text] [Related]
18. Cellular protein hnRNP-A1 interacts with the 3'-end and the intergenic sequence of mouse hepatitis virus negative-strand RNA to form a ribonucleoprotein complex.
Zhang X; Li HP; Xue W; Lai MM
Adv Exp Med Biol; 1998; 440():227-34. PubMed ID: 9782285
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA.
Huang P; Lai MM
J Virol; 2001 Jun; 75(11):5009-17. PubMed ID: 11333880
[TBL] [Abstract][Full Text] [Related]
20. Both RNA-binding domains in heterogenous nuclear ribonucleoprotein A1 contribute toward single-stranded-RNA binding.
Shamoo Y; Abdul-Manan N; Patten AM; Crawford JK; Pellegrini MC; Williams KR
Biochemistry; 1994 Jul; 33(27):8272-81. PubMed ID: 7518244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]